Pfizer (BUE:PFE) Short Interest


BUE:PFE Pfizer Inc BUE:PFE
58 GF Score
Price ARS9,620.00
GF Value ARS10,141.47
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Pfizer Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BUE:PFE vs GILD, BMY, AMGN: Short Interest Comparison

For the Drug Manufacturers - General subindustry, Pfizer's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pfizer Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Short Interest distribution charts can be found below:

* The bar in red indicates where Pfizer's Short Interest falls into.


BUE:PFE
58GF Score
Pfizer Inc BUE:PFE
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pfizer (BUE:PFE) Overvalued in 2026?

Based on GuruFocus' analysis, Pfizer stock appears to be undervalued. The current stock price of ARS9,620.00 is trading 5.1% below its estimated GF Value™ of ARS10,141.47. GuruFocus considers Pfizer to be Fairly Valued.

Key valuation signals for BUE:PFE:

  • Short Interest:
  • GF Value™: ARS10,141.47 vs. price of ARS9,620.00 (5.1% below fair value)
  • GF Score™: 58/100 with 5 warning signs

No single metric tells the full story. See the BUE:PFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pfizer Business Description

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
58GF Score

Get the complete analysis for BUE:PFE

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS9,620.00
Price
ARS10,141.47
GF Value